Holen Sie sich die Stockscreener-App
74.06
0.20%
0.15
Handel nachbörslich:
74.06
Schlusskurs vom Vortag:
$73.91
Offen:
$73.92
24-Stunden-Volumen:
3.41M
Relative Volume:
1.29
Marktkapitalisierung:
$16.47B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
30.73
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
+0.15%
1M Leistung:
+8.56%
6M Leistung:
+36.74%
1J Leistung:
-10.04%
1-Tages-Spanne:
$73.86
$74.22
1-Wochen-Bereich:
$73.85
$74.22
52-Wochen-Spanne:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.06 | 16.45B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 - BioSpace
Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Hologic Tops Expectations And Receives Buyout Offer From Blackstone - Finimize
Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates - Yahoo! Finance Canada
Hologic Inc Surpasses Revenue and Non-GAAP EPS Estimates in Q4 2025 with $1.13 EPS and $1.05 Billion Revenue - GuruFocus
Hologic: Fiscal Q4 Earnings Snapshot - KVUE
Hologic (NASDAQ:HOLX) Exceeds Q3 Expectations - TradingView
Earnings Flash (HOLX) Hologic, Inc. Posts Q4 Adjusted EPS $1.13 per Share, vs. FactSet Est of $1.10 - MarketScreener
How to recover losses in Hologic Inc. stockBuy Signal & Low Risk High Reward Ideas - newser.com
How Hologic Inc. (HO1) stock reacts to weak economyCPI Data & Weekly Return Optimization Plans - newser.com
What margin trends mean for Hologic Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
How Hologic Inc. stock benefits from tech adoptionTrend Reversal & Daily Volume Surge Signals - newser.com
Will Hologic Inc. stock attract ESG investorsJuly 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
How Hologic Inc. (HO1) stock compares with market leaders2025 Breakouts & Breakdowns & Consistent Profit Alerts - newser.com
Breast Imaging Software Market Trends, Investment - openPR.com
Statistical indicators supporting Hologic Inc.’s strengthMarket Movement Recap & AI Driven Price Forecasts - newser.com
Hologic Inc. recovery potential after sell offEarnings Risk Report & Precise Trade Entry Recommendations - newser.com
October M&A: Bristol Myers, Thermo Fisher, Hologic and Boston Scientific - The Business Journals
Why retail investors pile into Hologic Inc. stock2025 Growth vs Value & Technical Pattern Based Buy Signals - newser.com
X-Ray System Markets Trends and Forecasts, 2020-2024 & - GlobeNewswire
Mammography Devices Market Trends and Forecasts Report - GlobeNewswire
Mammography Devices Market Trends and Forecasts Report 2025-2033, Profiles of Key PlayersHologic, Siemens Healthineers, GE Healthcare, Fujifilm, and Philips Healthcare - Yahoo! Finance Australia
Does Hologic Inc. stock trade at a discount to peersJuly 2025 Reactions & Growth Focused Stock Reports - newser.com
How Hologic Inc. (HO1) stock responds to bond marketJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
How high can Hologic Inc. stock goPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Using Ichimoku Cloud for Hologic Inc. technicalsJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Should you hold or exit Hologic Inc. nowStock Surge & Risk Adjusted Buy/Sell Alerts - newser.com
Real time breakdown of Hologic Inc. stock performanceWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
U.S., Europe, and Asia Pacific Molecular Diagnostics Market - openPR.com
Is Hologic Inc. (HO1) stock bottoming after sell offJuly 2025 Summary & Accurate Technical Buy Alerts - newser.com
Hologic Q4 2025 Earnings Preview - MSN
Assessing Hologic’s Outlook After New Launches and an 8.3% Share Price Jump - Yahoo! Finance Australia
Hologic (HOLX) Reports Q3: Everything You Need To Know Ahead Of Earnings - TradingView
HOLOGIC Earnings Preview: Recent $HOLX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Hologic Q3’25 slides: modest growth continues amid mixed segment performance By Investing.com - Investing.com South Africa
Hologic Q3’25 slides: modest growth continues amid mixed segment performance - Investing.com
Earnings call transcript: Hologic’s Q3 2025 shows stable growth - Investing.com
Hologic Inc. stock momentum explainedRate Hike & Reliable Price Breakout Signals - newser.com
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):